Adynxx, Inc. (ADYX)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Dec 1, 2025
Adynxx Market Cap
Adynxx has a market cap or net worth of $6 as of December 4, 2025. Its market cap has decreased by -100.00% in one year.
Market Cap
6.00
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since May 6, 2019, Adynxx's market cap has decreased from 52.42M to 6.00, a decrease of -100.00%. That is a compound annual growth rate of -91.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 6.00 | - |
| Dec 30, 2024 | 6.00 | -99.48% |
| Dec 31, 2021 | 1.16K | -99.95% |
| Dec 31, 2020 | 2.50M | -65.60% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 6, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 819.20M |
| Elite Pharmaceuticals | 573.51M |
| Glass House Brands | 520.12M |
| CytoDyn | 416.55M |
| Northwest Biotherapeutics | 382.32M |
| American Oncology Network | 363.17M |
| Silence Therapeutics | 311.27M |
| Nika Pharmaceuticals | 259.91M |